| Literature DB >> 27733204 |
Sujeong Mun1, Kihyun Park1, Younghwa Baek1, Siwoo Lee1, Jong-Hyang Yoo2.
Abstract
BACKGROUND: Because the world population is aging, it has become increasingly important to focus on and meet the healthcare needs of elderly individuals. This study aims to evaluate the relationships among common symptoms experienced by the elderly, including fatigue, pain, sleep disturbance, indigestion, and depression/anger/anxiety, and to assess how these symptoms affect health-related quality of life (HRQoL) in the elderly population after adjusting for sociodemographic characteristics and diagnosed diseases.Entities:
Keywords: Depression; Elderly; Fatigue; Health-related quality of life; Indigestion; Pain; Sleep disturbance
Mesh:
Year: 2016 PMID: 27733204 PMCID: PMC5062872 DOI: 10.1186/s12955-016-0549-9
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Socioeconomic characteristics and self-reported prevalence of symptoms and diseases in the study participants
| Characteristics | Participants | |
|---|---|---|
|
| ||
| Mean age, years (SD) | 70.0 (5.9) | |
| Education, | Less than elementary school | 502 (37.8) |
| Elementary school | 542 (40.8) | |
| Middle school | 179 (13.5) | |
| High school or higher | 105 (7.9) | |
| Living alone, | Yes | 317 (23.9) |
| No | 1011 (76.1) | |
| Household incomea, 10,000 won/month, | < 50 | 293 (23.0) |
| 50–99 | 469 (36.8) | |
| 100–199 | 362 (28.4) | |
| ≥ 200 | 152 (11.9) | |
| Symptoms, | Fatigue | 728 (54.8) |
| Pain | 755 (56.9) | |
| Sleep disturbance | 443 (33.4) | |
| Indigestion | 335 (25.2) | |
| Depression/anger/anxiety | 353 (26.6) | |
| Number of symptoms, | 0 | 314 (23.6) |
| 1 | 257 (19.4) | |
| 2 | 274 (20.6) | |
| 3 | 211 (15.9) | |
| 4 | 184 (13.9) | |
| 5 | 88 (6.6) | |
| Diagnosed diseasesb, | Hypertension | 889 (66.9) |
| Obesity | 690 (52.0) | |
| Dyslipidemia | 555 (41.8) | |
| Arthritis | 399 (30.0) | |
| Diabetes mellitus | 217 (16.3) | |
aFifty-two participants (3.9 %) refused to answer the question related to household income
bOf the collected information on twenty-eight diseases, the five most prevalent diseases are listed in the table
Pairwise associations between each symptom measured by ORs of the increased prevalence of one symptom in the presence of the others
| Fatigue | Pain | Sleep disturbance | Indigestion | Depression/anger/anxiety | |
|---|---|---|---|---|---|
| Fatigue | - | ||||
| Pain | 8.127 (6.234 to 10.596) | - | |||
| Sleep disturbance | 3.155 (2.417 to 4.119) | 3.124 (2.376 to 4.107) | - | ||
| Indigestion | 3.228 (2.401 to 4.339) | 3.202 (2.362 to 4.341) | 2.521 (1.921 to 3.308) | - | |
| Depression/anger/anxiety | 5.157 (3.719 to 7.151) | 4.115 (2.973 to 5.696) | 5.111 (3.846 to 6.793) | 2.500 (1.872 to 3.338) | - |
The estimated ORs by the logistic regression were adjusted for gender, age, income, education, and solitary living
Fig. 1Severity of each symptom according to the presence of any other symptom. Light blue represents individuals with only one of the corresponding symptoms on the x-axis. Blue represents individuals with any other symptoms in the presence of the corresponding symptom. Symptom severity was assessed on a seven-point Likert scale ranging from one to seven
Fig. 2EQ-5D index scores (a) and EQ VAS scores (b) by number of symptoms
Estimated ORs of each symptom among the EQ-5D dimensions
| EQ-5D dimensions | ||||||
|---|---|---|---|---|---|---|
| Mobility | Self-care | Usual activities | Pain/discomfort | Anxiety/depression | ||
| Symptoms | Fatigue | 2.179** (1.680 to 2.827) | 1.678** (1.186 to 2.375) | 1.762** (1.366 to 2.271) | 2.167** (1.670 to 2.811) | 1.986** (1.533 to 2.571) |
| Pain | 2.996** (2.301 to 3.902) | 1.643** (1.149 to 2.350) | 1.993** (1.538 to 2.583) | 3.106** (2.376 to 4.060) | 1.498** (1.154 to 1.944) | |
| Sleep disturbance | 1.737** (1.311 to 2.301) | 1.596** (1.142 to 2.231) | 1.394* (1.071 to 1.814) | 1.585** (1.187 to 2.118) | 2.573** (1.977 to 3.351) | |
| Indigestion | 1.126 (0.835 to 1.517) | 1.258 (0.872 to 1.813) | 1.320 (0.993 to 1.754) | 1.864** (1.348 to 2.578) | 1.502** (1.134 to 1.988) | |
| Depression/anger/anxiety | 1.187 (0.874 to 1.612) | 1.376 (0.963 to 1.967) | 1.340* (1.007 to 1.784) | 1.788** (1.285 to 2.490) | 5.843** (4.309 to 7.923) | |
The probability of reporting moderate or extreme problems in the respective EQ-5D dimension was used as the dependent variable. All estimates were adjusted for gender, age, income, education, and solitary living. *, p < 0.05; **, p < 0.01
Multiple regression analysis of the EQ-5D index and EQ VAS scores
| EQ-5D index | EQ VAS score | |||||
|---|---|---|---|---|---|---|
| B | SE |
| B | SE |
| |
| Gender (reference: male) | ||||||
| Female | −0.037 | 0.009 | −0.127** | −0.806 | 1.159 | −0.024 |
| Age | −0.002 | 0.001 | −0.077* | −0.066 | 0.089 | −0.024 |
| Education (reference: less than elementary school) | ||||||
| Elementary school | 0.034 | 0.009 | 0.123** | 0.190 | 1.124 | 0.006 |
| Middle school | 0.042 | 0.013 | 0.106** | 0.112 | 1.606 | 0.002 |
| High school or higher | 0.062 | 0.015 | 0.123** | −0.093 | 1.917 | −0.002 |
| Living alone (reference: no) | ||||||
| Yes | 0.003 | 0.010 | 0.010 | 3.055 | 1.205 | 0.082* |
| Household income (10,000 won/month) (reference: < 50) | ||||||
| 50-99 | −0.008 | 0.010 | −0.028 | −1.085 | 1.286 | −0.033 |
| 100-199 | −0.010 | 0.011 | −0.034 | 1.857 | 1.443 | 0.053 |
| ≥ 200 | −0.002 | 0.014 | −0.006 | 1.434 | 1.803 | 0.030 |
| Fatigue | −0.020 | 0.008 | −0.073* | −2.206 | 1.064 | −0.070* |
| Pain | −0.039 | 0.009 | −0.140** | −1.344 | 1.070 | −0.042 |
| Sleep disturbance | −0.018 | 0.008 | −0.061* | −2.145 | 1.062 | −0.063* |
| Indigestion | 0.007 | 0.009 | 0.022 | −0.705 | 1.111 | −0.019 |
| Depression/anger/anxiety | −0.020 | 0.009 | −0.065* | −1.971 | 1.185 | −0.054 |
| Diagnosed diseases | ||||||
| Arthritis | −0.043 | 0.008 | −0.144** | −3.135 | 1.031 | −0.090** |
| Osteoporosis | −0.025 | 0.010 | −0.066* | −4.087 | 1.322 | −0.092** |
| Parkinson’s disease | −0.104 | 0.046 | −0.059* | −11.656 | 5.785 | −0.057* |
| Asthmaa or Chronic hepatitisb | −0.035 | 0.016 | −0.056* | −11.890 | 4.437 | −0.076** |
| Dyslipidemiaa or Allergyb | −0.015 | 0.007 | −0.055* | −4.955 | 2.136 | −0.066* |
| Chronic gastritis | −0.022 | 0.010 | −0.056* | −3.524 | 1.285 | −0.079** |
| R2 | 0.249 | 0.098 | ||||
| Adjusted R2 | 0.236 | 0.082 | ||||
B unstandardized coefficients, SE standard error of unstandardized coefficients, β standardized coefficients
* p < 0.05; ** p < 0.01, aSelected using a forward stepwise selection in a regression model for the EQ-5D index
bSelected using a forward stepwise selection in a regression model for the EQ VAS